Kaplan MN553 Final Exam Answers Part 1
Question 1
Question 1
The Best Pharmaceuticals for Children Act:
Includes a pediatric exclusivity rule which extends the patent on drugs studied in children
Establishes a committee that writes guidelines for pediatric prescribing
Provides funding for new drug development aimed at children
Encourages manufacturers specifically to develop pediatric formulations
Question 2
1 / 1 point
Patient education regarding taking iron replacements includes:
Doubling the dose if they miss a dose to maintain therapeutic levels
Taking the iron with milk or crackers if it upsets their stomach
Iron is best taken on an empty stomach with juice
Antacids such as Tums may help the upset stomach caused by iron therapy
Question 3
1 / 1 point
The benefits to the patient of having an Advanced Practice Registered Nurse (APRN) prescriber include:
Nurses know more about Pharmacology than other prescribers because they take it both in their basic nursing program and in their APRN program.
Nurses care for the patient from a holistic approach and include the patient in decision making regarding their care.
APRNs are less likely to prescribe narcotics and other controlled substances.
APRNs are able to prescribe independently in all states, whereas a physician’s assistant needs to have a physician supervising their practice.
Question 4
1 / 1 point
Precautions that should be taken when prescribing controlled substances include:
Faxing the prescription for a Schedule II drug directly to the pharmacy
Using tamper-proof paper for all prescriptions written for controlled drugs
Keeping any pre-signed prescription pads in a locked drawer in the clinic
Using only numbers to indicate the amount of drug to be prescribed
Question 5
1 / 1 point
The reason that two MMR vaccines at least a month apart are recommended is:
The second dose of MMR “boosts” the immunity built from the first dose.
Two vaccines 1 month apart is the standard dosing for all live virus vaccines.
If the two MMR vaccine doses are given too close together there is a greater likelihood of severe localized reaction to the vaccine.
Only 95% of patients are fully immunized for measles after the first vaccine, with 99% having immunity after two doses of MMR.
Question 6
1 / 1 point
Instructions for the use of nicotine gum include:
Chew the gum quickly to get a peak effect.
The gum should be “parked” in the buccal space between chewing.
Acidic drinks such as coffee help with the absorption of the nicotine.
The highest abstinence rates occur if the patient chews the gum when he or she is having cravings.
Question 7
1 / 1 point
Leonard is completing a 6-month regimen to treat tuberculosis (TB). Monitoring of a patient on TB therapy includes:
Monthly sputum cultures
Monthly chest x-ray
Bronchoscopy every 3 months
All of the above
Question 8
1 / 1 point
Severe contact dermatitis caused by poison ivy or poison oak exposure often requires treatment with:
Topical antipruritics
Oral corticosteroids for 2 to 3 weeks
Thickly applied topical intermediate-dose corticosteroids
Isolation of the patient to prevent spread of the dermatitis
XXXXXXXX X
X / X point
The XXXX XX XXX XX in XXX use of herbal XXXXXXXXXX XX XX:
XXXXXXXX XXXXXXXXXX in the XXXXXXXXXXX of XXXXXX herbal XXXXXXXX
Recommend common over-XXX-counter XXXXX XX patients
XXXXXXX patients and guide them to appropriate sources of care
XXXXXXXXX XXXXXXXX to XXX use herbal XXXXXXX due XX XXX XXXXXXXXXX dangers
XXXXXXXX XX
1 / 1 XXXXX
Elena Vasquez’s primary language XX Spanish, and XXX speaks XXXX XXXXXXX English. Which technique would be XXXXXXXXXXX XX XXX in XXXXXXXX her XXXXX a XXX XXXX you have just prescribed?
XXX XXXXXXX medical terminology because Spanish has a Latin XXXX.
XXX a family XXXXXX who XXXXXX more English to act XX an interpreter.
Use a XXXXXXXXXXXX interpreter or a reliable XXXXX member who can act as an interpreter.
XXX XXXXXXX, XXXXXXXX explanations.
XXXXXXXX 11
X / X XXXXX
A woman who is pregnant XXX XXX XXXXXXXXXXXXXXX is best managed by a XXXXXXXXX team XXX XXXX XXXX XXXXXX treat her with:
Methimazole
XXXXXXXXXXXXXXXX (PTU)
Radioactive iodine
XXXXXXX, XXXXXXXXX XX best delayed until after her XXXXXXXXX ends
Question 12
X / X XXXXX
The first-line drug XXXXXX XXX a previously healthy adult patient XXXXXXXXX with XXXXXXXXX-acquired XXXXXXXXX would XX:
XXXXXXXXXXXXX
Azithromycin
Amoxicillin
Doxycycline
XXXXXXXX XX
1 / 1 point
XXXXX is a 90-XXXX-old XXXXXXX XXX XXXXXXXX a XXX prescription. XXXX changes in drug XXXXXXXXXXXX XXXX XXXXX XXXXX influence XXXXXXXXXXX for Sadie?
XXXXXXXXX volume XX distribution
XXXXXXXXX lipid XXXXXXXXXX
XXXXXXXXX XXXXXX XXXXXXXX
XXXXXXXXX XXXXXX-to-XXX ratio
XXXXXXXX 14
X / X point
XXXXXXXX XXX are prescribed exogenous XXXXXXXXX need to XX XXXXXX that XXXXXXXXX XXXXXX:
Is an XXXXXXX XXXX effect of XXXXXXXXX XXX XXXXXX be XXXXXXXX to the provider
XX XXXXXXX with increased doses XX XXXXXXXXX, so the patient XXXXXX let XXX provider know if he XX having XXXXXXXX
XXX be a sign XX early prostate XXXXXX XXX he should XXXX an appointment for a prostate screening exam
XXX XXXXX with XXXXXXXX therapy
XXXXXXXX 15
X / X XXXXX
XXXXXXXXX XX XXXXX who XXX XXXXX XXXXXXX with ophthalmic XXXXXXXXXXX for XXXXXXXXXXXXXX XXXXXXXX:
XXXXXXXX XXXX eye XXXXXX XXX XXXXXXXXXX XXX
Redness XXX intense XXXXXXX XX normal with ophthalmic XXXXXXXXXXX
XXXX applying XXX XXXXXXXX, XXX the XXX of XXX XXXX on the XXXXX lid and squeeze in inch
Use a XXXXXX swab to apply XXXXXXXX, XXXXXXXXX the ointment XXX XXXX the lid XXX in XXX conjunctival XXX
XXXXXXXX XX
X / X XXXXX
XXXXXXX states in XXXXXXXX to hypertension in XXXXX XXXX XXXXXXXX XX a XXXXXXXXXX XXXXXXXXXX XXX the XXX of beta blockers include:
Heart failure
XXXXXX
Myocardial infarction
Dyslipidemia
Question XX
1 / X point
XXXX is the XXXX XX calcium XXXXXXXXXXX when XXXXXXXX XXXX XXXXXXXXXXXXXXX?
XXXX must XX restricted to allow the medication to work.
They XXXX be XXXXX in sufficient XXXXXXX to provide XXXXXXXXXXXX XXXXXXXX for bone growth.
They XXXX XX taken XX XXX same time as XXX XXXXXXXXXXXXXXX.
They only XXXX XXXX XXXXXXXXXXXXXXX XX XXXXX XXXXXX XX restricted.
Question XX
X / 1 point
Isosorbide XXXXXXXXX is prescribed XXX a patient XXXX XXXXXXX XXXXXX angina. This drug XX administered twice XXXXX, but the XXXXXXXX XX X a.m. and X p.m. because:
XX XX a long-acting drug XXXX potential XXX XXXXXXXX.
XXXXXXX tolerance XXX XXXXXXX.
Orthostatic XXXXXXXXXXX XX a common adverse XXXXXX.
It XXXX be XXXXX XXXX milk or food.
Question 19
X / 1 point
XX an adult patient XXXX comorbidities cannot reliably XXXX XXXX antibiotics to XXXXX pneumonia, an XXXXXXXXXXX initial treatment option XXXXX be:
XX or XX gentamicin
XX or XX ceftriaxone
IV amoxicillin
IV XXXXXXXXXXXXX
XXXXXXXX 20
1 / X point
XXX XXXXXX XXXXXXXXXXXXXXX XXXXXXXX XXX, which is XXXX XX XXX XXXX X.S. Patriot XXX:
Requires all XXXXXXXXX to screen XXXXX patients for methamphetamine XXX
Restricts XXX prescribing of amphetamines XX U.S. citizens
Requires a prescription be written XXX XXX XXXXXXXXXXXXXXX precursors in all XXXXXX
Restricts XXX sales of XXXXX that XXXXXXX methamphetamine XXXXXXXXXX, XXXXXXXXX a daily and XX-day limit XX sales
Question XX
1 / 1 XXXXX
XXX optimal XXXXXXX time frame XXX HRT or XXXXXXXX replacement therapy (ERT) is:
X XXXXX
X XXXXX
XX years
15 XXXXX
Question 22
1 / 1 XXXXX
XXXXXXX XX a XX-year-old XXXXXXX who presents with XXXXXXXXXXXXX XXXXXXXXXXXX. Along XXXX diet XXXXXXX, a laxative XX ordered XX XXXXXXX XXXX XXXXX relief XX constipation. An XXXXXXXXXXX XXXXXX XX XXXXXXXXXX for a XX-XXXX-old XXXXX would be:
PEG 3350 (Miralax)
Bisacodyl (XXXXXXXX) XXXXXXXXXXX
XXXXXXXX (Colace) suppository
XXXXXXXXXXXX glycol XXXXXXXXXXX XXXXXXXX
Question 23
X / 1 point
XXXXXXXXXXXX XX especially XXXXXX in XXXXX XXXX XXXXX XXXXXXXXXXXX XXXXXXXXXX, XXXX as XXXXXXXXXXXX. XXX XXX to reduce XXX likelihood of nonadherence to XXXXX drugs XX XX XXXXXXXXX a XXXX XXXX:
Has a short half-life so that XXXXXXX XXX dose XXX limited effect
XXXXXXXX XXXXXXX XXXXXX XXXXXXXXXX so XXXX XXXXXX doses can XX XXXXXXXX with XXXXX XXXXX XX XXXX costs down
XXX a tolerability profile XXXX XXXXX XX the XXXXXXX XXXXXXX XXXX XXX considered “irritating,” such XX XXXXXX XXX XXXXXXXXX
XXXX be taken no more XXXX twice a day
Question XX
1 / 1 XXXXX
Larry is taking XXXXXXXXXXX XX prevent gout. XXXXXXXXXX XX a XXXXXXX who is taking allopurinol XXXXXXXX:
XXXXXXXX blood XXXXX
Blood XXXXXXX
C-reactive XXXXXXX
XXX, XXXXXXXXXX, XXX creatinine XXXXXXXXX
XXXXXXXX XX
X / X point
A XXXXXXXXXX XXXXXX XXXXXXXXX XXXX the peak XXXXX for a XXXX XX above XXX XXXXXXX XXXXX concentration. XXXX XXXXX XXXX XXX:
Concentration XXXX XXXXXXX therapeutic XXXXXXX
Concentration XXXX produce an XXXXXXX response
XXXX XXXXXXX doses must XX XXXXXXXXX
Duration XX action of XXX drug XX XXX long
XXXXXXXX XX
1 / X XXXXX
XXX XXX York Heart XXXXXXXXXXX XXX the Canadian XXXXXXXXXXXXXX XXXXXXX XXXX XXXXXXXXX XXXXXXX criteria for levels XX angina. XXXXXX that XXXXXX with XXXXXXXXX XXXXXXXXX activity or on XXXXXXX or climbing stair after XXXXX is XXXXX:
I
II
XXX
IV
Question 27
1 / 1 point
XXXXXXX XXX XXXX XXXXXX XX XXXXX moderate to severe pain. Which XX the following XX NOT true about XXXXX XXXXX?
XXX XXXXXXX XXX XXXXXXXXX drugs XXXXX XXXXXXX a XXX license XX prescribe.
XXXXXXX stimulate XXXX mu XXXXXXXXX XXX the XXXXXXX of pain.
Most of XXX XXXXXXX XXXXXXX XX opiates XXX related XX XX receptor XXXXXXXXXXX.
Naloxone is an XXXXXXXXXX to opiates.
XXXXXXXX XX
1 / 1 XXXXX
Several classes of drugs XXXX XXXXXXXXXXXX XXXX cholinergic XXXXXXXX. Which XX XXX following XX true XXXXX these interactions?
XXXXX with a XXXXXX XXXXXXXXXXX range XXXXX orally XXX XXX stay in the XX tract XXXX enough to XXXXXXX an XXXXXX.
Additive antimuscarinic XXXXXXX may occur with antihistamines.
Cholinergic XXXXXXXX XXX XXXXXXXX the sedative XXXXXXX XX hypnotics.
Cholinergic XXXXXXXX are contraindicated XXXX XXXXXXXXXXXXXX.
Question XX
X / 1 point
XXXX is a XX-month-XXX male whose screening hemoglobin is 10.4 g/dL. Treatment for XXX anemia would be:
XX XX/day XX iron XXXXXXXXXXXXXXX
6 mg/kg per day XX elemental XXXX
XXX mg XXXXXXX sulfate XXX day
XXX XX ferrous XXXXXXX XXX
Question 30
1 / X point
XXXXX when XXXXXXXX tuberculosis XXXXXXX:
Completion XX XXXXXXXXXXX therapy
XXXXXXXX XXXXXXXX protein XXXXXXXXXX XX the XXX of XXXXXXX
Completely normal XXXXX x-ray
All of the XXXXX
Question 31
1 / 1 XXXXX
The first-XXXX therapy XXX mild-persistent asthma XX:
XXXX-dose montelukast
Theophylline
XXX-XXXX XXXXXXX XXXXXXXXXXXXXXX
Long-XXXXXX beta-2-XXXXXXXX
XXXXXXXX 32
1 / X point
Gender XXXXXXXXXXX XXXXXXX men XXX XXXXX in XXXXXXXXXXXXXXXX XXXXXXX:
More XXXXX gastric XXXXXXXX so XXXX drugs absorbed in the stomach have XXXX XXXXXXXX XX absorption sites
XXXXXX proportion XX body fat so that XXXXXXXXXX drugs have XXXXXXXXXX XXXXXXX volumes of XXXXXXXXXXXX
XXXXXXXXX XXXXXX XX XXXX acids so that drugs metabolized in the intestine XXXX XXXXXX XXXXXXXXXXXXXX
XXXXXX organ XXXXX flow rates so drugs XXXX XX take XXXXXX XX XX XXXXXXXX
Question 33
X / X XXXXX
XXXXXXXXXXX (Chantix) may XX prescribed XXX tobacco cessation. XXXXXXXXXXXX XX the patient who is XXXXXXXX varenicline XXXXXXX:
The XXXXXXX XXXX XXXXXXXXXXX can XX used is 12 weeks.
Nausea is a XXXX of varenicline toxicity XXX should be reported XX XXX provider.
XXX XXXXXXXX XXXXXXX XXX varenicline XX start XXXXXX 1 mg XXXXX a XXX a XXXX before XXX XXXX XXXX.
XXXXXXXXXXXXXXXX symptoms XXX occur.
XXXXXXXX 34
1 / X XXXXX
Which of XXX XXXXXXXXX XX a primary XXXXXXX of the XXX of XXXXXXXXXXXX XXXXXXXX order entry XXX XXXXXXX XXXXXXXXXXX?
Reduces XXXX that prescribing XXXXX XXXXX
XXXXXXXXXX the XXXX XX chart XXXXX XXXXXXXXXX
XXXXXXXXX prescribing and transcription XXXXXX
XXXXX keep the number XX XXXXX XXXXXXXXXX to a minimum
XXXXXXXX 35
1 / 1 point
XXX XXXX XXXX-XXXXXXXXX treatment XXX two or three impetigo XXXXXXX XX the face XX:
XXXXXXXXX XXXXXXXX
XXXXXXXXXXX (XXXXXXX) ointment
XXXXXXX clindamycin XXXXXXXX
XXXX XXXXXXXXXXX/clavulanate (XXXXXXXXX)
Question XX
X / 1 XXXXX
XXXXXXXX XXX XXXX a XXXX metabolism phenotype will have:
XXXXXX metabolism of a XXXXXXX into an active XXXX, XXXXXXX XX XXXXXXXXXXXX XX XXXXXXX
XXXXXXXXXXXX XX XXXXXXXX metabolites of drugs
X XXXX XXX increased dosages of medications
Increased elimination of an XXXXXX XXXX
XXXXXXXX 37
1 / 1 point
XXXXXXXXXX XXX XXXXXXXX who are XX long-XXXX antifungal therapy with ketoconazole XXXXXXXX:
Platelet XXXXX
BUN XXX creatinine
White XXXXX cell XXXXX
AST, ALT, XXXXXXXX phosphatase, and XXXXXXXXX
Question XX
1 / X point
XXXX a pharmacoeconomic XXXXXXXX XXXXX XX XXX or more treatment alternatives that are XXXXXXXXXX equal in efficacy and compares XXX costs XX each it is referred to as:
Cost-XXXXXXXXXXXX analysis
XXXX-of-illness analysis
XXXX-XXXXXXXXXXXXX XXXXXXXX
Cost-benefit XXXXXXXX
Question 39
1 / X XXXXX
When considering which XXXXXXXXXXX-lowering drug XX prescribe, XXXXX factor determines the type XXX intensity of XXXXXXXXX?
XXXXX XXX
Fasting XXX
XXXXXXXX artery XXXXXXX XXXX XXXXX
Fasting XXXXX cholesterol
XXXXXXXX XX
X / 1 point
Sally XXX been prescribed aspirin XXX mg XXX XXX XXX her XXXXXX XXXXXXXXXXXX. She also takes aspirin XXXX or XXXX times a XXX for XXXXXXXXX XXXX. XXXX XXX XXX XXXXXXXX XX XXXXXXX XXXXXXXX for XXXXX XXX XXXXX need to be evaluated?
XXXXXXXX
Diarrhea
Hearing XXXX
XXXXXXXXXXXXXXXX
Question 41
X / 1 point
Patients XXX are on XXXXXXX XXXX-term XXXXXX XXXX inhibitor therapy require monitoring for:
XXXX XXXXXXXXXX XXXXXX, XXXXXXX B12 XXX XXXXXXX deficiency
Folate and magnesium deficiency
XXXXXXXX uric acid XXXXXX XXXXXXX to XXXX
Hypokalemia and hypocalcemia
XXXXXXXX 42
1 / X XXXXX
XXXXX XX XXX XXXXXXXXX XXXXX XXXX XXX the XXXXXXXXXXXXXXXX XX XXXXX?
Gastric emptying XX faster XXXX that of men.
Organ XXXXX XXXX XX the XXXX as that XX XXX.
Evidence is XXXXXX XXXXXXXXXX XXXXX differences in XXXXXXXXXXX.
XXXXXXXXXXX XXXX XXXXXXX XXXXXXX XXXXXXXXX XXX XXXXXXXX XX XXXXXXXX levels.
Question XX
X / 1 point
XXXXXXX has been XXXXXXXXXX citalopram (Celexa) to XXXXX XXX XXXXXXXXXX. XXXXXXXXX XXXXXXXXX how quickly selective XXXXXXXXX reuptake inhibitor (SSRI) antidepressants XXXX XXXXX XX:
XXXXXXXX and concentration XXXXXXX in the XXXXX 1 XX 2 weeks.
Sleep XXXXXX XXXXXXX XXXXXX immediately upon starting citalopram.
Full XXXXXXXX XX the XXXX may XXXX 2 XX X XXXXXX after he reaches XXX XXXX XXXXXXXXXXX dose.
XXX XXXXXXXXX XXXX XXXX XXXXXXX in X to 2 weeks.
XXXXXXXX XX
1 / X point
XXXXX XXXXXXXXX in the use XX XXXXXXXXXXX XXXXXXXXXX in clinical XXXXXXXX is expected in XXXXXXXXXXXX nurses. XXXXXXXX XXXXXXXX competence includes XXX XXXXXXX to:
XXXXXX XXX XXXXXXXXXXX XXXXX XXX most XXXXXX search engines
Serve as content experts in developing, implementing, XXX XXXXXXXXXX information XXXXXXX
Write programs XX XXXXXX XXX integrity of XXXXXX information
Use XXXXXXXXXXX technology to XXXXXXXXX drugs
Question XX
X / 1 point
According XX XXX U.S. XXXXXX of Minority XXXXXX, poor health XXXXXXXX XXXXX African Americans are attributed XX:
XXX belief XXXXX African XXXXXXXXX that XXXXXX XX more XXXXXXXX than XXXXX
XXXX compliance on XXX XXXX of XXX African American XXXXXXX
XXX XXXXXXX XXXXXXXXXXXXXX for XXXXXXX found XXXXX XXXXXXX XXXXXXXXX
Discrimination, cultural barriers, and lack of XXXXXX to health care
XXXXXXXX 46
1 / 1 XXXXX
XXXX has been prescribed XXXXXXXXXX to XXXXX neuropathic pain and is XXXXXXXXXXX XX feeling XXXXXXXXX XXX having “XXXXXXX” XXXXXXXX. XXX XXXXXXXXXXX XXXXXXX action XXXXX be:
Increase her dose
XXXXXX for XXXXXXXX XXXXXXXX
Discontinue XXX medication XXXXXXXXXXX
Decrease her dose to half XXXX slowly XXXXXXX XX the dose
XXXXXXXX 47
X / 1 point
X XXXXXXXX may XXXXXXXX testing XXX XXXXXX XXXXXXXX XXXXX to starting XXXXXXXXX for breast XXXXXX to:
XXXXXX the patient XXXX not XXXX XXXXXXXXX XXXXXXX XXXX reactions to XXX tamoxifen
Identify potential XXXX-drug interactions that XXX XXXXX XXXX XXXXXXXXX
XXXXXX XXX likelihood of XXXXXXXXXXX failure with tamoxifen treatment
XXXXXXXX XXXX XXXXXXXXXXXX of tamoxifen
XXXXXXXX XX
X / X XXXXX
Male XXXXXXXX who XXXXXX XXX be XXXXXXXXXX phosphodiesterase type X (PDE-X) XXXXXXXXXX include:
XXXXXXXXX
XXXXX XXX have had an XXXXX XXXXXXXXXX infarction in XXX past X months
Patients who are XXXX
Patients XXXXX age XX years XX age
XXXXXXXX 49
1 / X XXXXX
True contraindications XX XXXXXXXXXX, XXXXXXX, XXX XXXXXXXXX XXXXXXXXX (XXXX or Tdap) vaccine XXXXXXX:
XXXXX up XX XXXXX (XX.5oC) after XXXXXXXX DTaP XXXXXXX
Family XXXXXXX of seizures XXXXX XXXX vaccine
XXXXXXXXXX pregnancy
Anaphylactic XXXXXXXX XXXX a previous dose
Question XX
1 / 1 XXXXX
XXXXX the XXXXXXXXX XXXXXXX should XXX have a statin medication ordered?
Someone with 3 XXXXX- or XXXXXX-degree family XXXXXXX XXXX XXXXXXX of muscle XXXXXX XXXX XXXXXXX XX statins
XXXXXXX XXXX XXXX lipids, XXX XXX XXX
XXXXXXXXXXXXX woman XXXX XXXXXX XXXXXXX XX XXXXXXXXXXXX
Prediabetic XXXX XXXX known XXXXXXXXX XXXXXXXX
XXXXXX
X. Establishes a committee XXXX writes XXXXXXXXXX for pediatric XXXXXXXXXXX
X. Iron is XXXX taken XX an empty stomach with XXXXX
3. XXXXXX care for XXX XXXXXXX XXXX a holistic XXXXXXXX and XXXXXXX XXX XXXXXXX in decision making regarding their care.
4. Using tamper-proof paper for all XXXXXXXXXXXXX written XXX controlled XXXXX
X. Only 95% XX patients are XXXXX immunized XXX measles XXXXX XXX first XXXXXXX, with XX% having XXXXXXXX XXXXX two doses of XXX.
X. The gum XXXXXX XX “parked” in the buccal XXXXX between chewing.
X. Monthly sputum XXXXXXXX
8. Oral corticosteroids XXX 2 XX 3 XXXXX
X. XXXXXXX patients and guide XXXX XX XXXXXXXXXXX XXXXXXX of care
XX. Use a XXXXXXXXXXXX interpreter or a reliable staff XXXXXX who XXX XXX XX an XXXXXXXXXXX.
XX. XXXXXXXXXXXXXXXX (XXX)
12. XXXXXXXXXXXX
13. Decreased XXXXXX proteins
14. XXX occur with androgen XXXXXXX
XX. XXXXXXXX XXXX eye makeup and XXXXXXXXXX new
16. XXXXXXXXXX infarction
17. XXXX XXXX be taken in sufficient XXXXXXX XX provide XXXXXXXXXXXX XXXXXXXX for bone growth.
XX. Nitrate XXXXXXXXX can XXXXXXX.
XX. IV or IM ceftriaxone
20. XXXXXXXXX XXX sales XX drugs XXXX contain methamphetamine XXXXXXXXXX, including a daily and XX-XXX XXXXX XX sales
21. 5 years
22. Bisacodyl (XXXXXXXX) suppository
XX. XXX a XXXXXXXXXXXX profile XXXX XXXXX XX XXX adverse effects XXXX XXX considered “XXXXXXXXXX,” such as nausea and XXXXXXXXX
24. BUN, creatinine, XXX creatinine XXXXXXXXX
25. Concentration will produce an adverse XXXXXXXX
XX. XX
27. Opiates stimulate only mu XXXXXXXXX XXX the control XX XXXX.
28. Drugs XXXX a narrow therapeutic range given XXXXXX XXX XXX XXXX in XXX GI XXXXX long XXXXXX to XXXXXXX an XXXXXX.
29. X mg/kg XXX day XX XXXXXXXXX iron
XX. Completion XX recommended therapy
XX. Low-dose inhaled corticosteroids
XX. Higher XXXXXXXXXX of body XXX so that lipophilic XXXXX have XXXXXXXXXX XXXXXXX volumes of distribution
33. Neuropsychiatric symptoms may XXXXX.
34. XXXXXXXXX prescribing and XXXXXXXXXXXXX XXXXXX
XX. XXXXXXXXX ointment
XX. XXXXXX metabolism of a prodrug XXXX an XXXXXX XXXX, leading XX XXXXXXXXXXXX XX XXXXXXX
XX. AST, XXX, alkaline XXXXXXXXXXX, XXX XXXXXXXXX
XX. XXXX-minimization analysis
XX. XXXXXXXX artery XXXXXXX risk XXXXX
XX. Tinnitus
41. XXXX XXXXXXXXXX XXXXXX, XXXXXXX XXX XXX XXXXXXX deficiency
XX. XXXXXXXXXXX that XXXXXXX XXXXXXX globulins are XXXXXXXX XX XXXXXXXX levels.
43. XXXXXXXX XXX concentration improve in the first X to X XXXXX.
44. Serve XX XXXXXXX experts in developing, implementing, and XXXXXXXXXX information XXXXXXX
45. XXXXXXXXXXXXXX, XXXXXXXX barriers, and lack XX XXXXXX to health XXXX
XX. XXXXXX XXX XXXXXXXX XXXXXXXX
47. XXXXXX the likelihood XX therapeutic XXXXXXX XXXX tamoxifen treatment
48. XXXXX who have had an XXXXX XXXXXXXXXX XXXXXXXXXX in the past 6 XXXXXX
49. Anaphylactic XXXXXXXX XXXX a previous XXXX
XX. XXXXXXX XXXX X first- or XXXXXX-degree family XXXXXXX XXXX history XX muscle issues XXXX XXXXXXX on XXXXXXX
">